PCN29 Time to Next Treatment As a Candidate Surrogate Endpoint for Overall Survival in Previously Untreated Advanced Melanoma Patients Treated with Immune-Checkpoint Inhibitors
Abstract
Authors
S. Branchoux C.L. Sofeu A.F. Gaudin M. Kurt A. Moshyk A. Italiano C. Bellera V. Rondeau